谵妄与不良临床结局:英国生物样本库匹配队列研究
该匹配队列研究纳入英国生物样本库中1997至2022年有住院记录的参与者,将14 909例住院期间发生谵妄的个体按年龄、性别、医院衰弱风险评分、主要诊断、指数住院时长和ICU时长1:1匹配无谵妄住院对照。
要点
- 院内谵妄与尿失禁、跌倒、压力性损伤、急性肾损伤、脓毒症等12项后续住院不良结局风险升高相关。
- 谵妄发作次数呈剂量反应关系,每增加一次发作,不良结局风险升高6-17%。
- 关联独立于衰弱和既往痴呆,提示谵妄为长期脆弱性的哨兵事件。
核心结论
- 院内谵妄与多种后续住院不良临床结局呈持续且剂量反应性的关联,独立于衰弱和既往痴呆,支持将其视为提示长期脆弱性的哨兵事件。
研究设计与样本
- 研究为在英国生物样本库住院参与者中开展的匹配队列研究,参与者招募于2006-10年,链接1997年1月1日至2022年10月31日的住院记录。
- 将14 909例谵妄个体按年龄、性别、医院衰弱风险评分、主要诊断、指数住院时长和ICU时长1:1匹配无谵妄住院对照。
- 谵妄通过ICD-10编码识别,暴露强度定义为指数入院后12个月内谵妄发作次数。
- 采用Fine-Gray子分布风险模型,将死亡作为竞争风险并调整社会经济协变量。
主要发现
- 每增加一次谵妄发作,不良结局风险升高6-17%。
- 排除短随访、既往痴呆及匹配最差配对后的敏感性分析结果一致。
临床怎么用
- 对住院期间发生谵妄的老年患者,应认识到其出院后仍面临跌倒、尿失禁、感染、骨折、卒中、心衰等多系统不良结局的长期风险。
- 谵妄发作次数与后续不良结局风险呈剂量反应关系,提示减少谵妄复发可能具有长期获益。
- 谵妄评估不应仅视为急性脑功能障碍,而可作为识别长期脆弱人群、安排出院后随访与多学科管理的哨兵事件。
局限性
- 谵妄通过ICD-10编码识别,可能存在漏诊或错分。
- 研究为观察性匹配队列,残余混杂不能完全排除。
- 研究人群为英国生物样本库参与者,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delirium complicates up to one in four hospitalisations among older adults, but its clinical sequelae beyond cognitive impairment, functional decline, and mortality are not well characterised. Whether delirium signals broader multisystem vulnerability leading to later adverse outcomes remains uncertain. We aimed to examine the association of in-hospital delirium with the occurrence of a range of adverse outcomes during later hospitalisations in the UK. METHODS: We performed a matched cohort study among hospitalised UK Biobank participants recruited in England, Scotland, and Wales in 2006-10 with linked hospital inpatient records collected from Jan 1, 1997 to Oct 31, 2022. We matched 14 909 individuals with delirium (1:1) to hospitalised control individuals without delirium by age, sex, Hospital Frailty Risk Score, primary diagnosis, episode length of stay, and intensive care unit length of stay of the index episode. The primary outcome was the risk of adverse clinical outcomes following delirium. Delirium was identified by ICD-10 codes, with exposure intensity defined as the number of episodes within 12 months of the index admission. Adverse clinical outcomes were selected based on existing literature and included incident events occurring during subsequent hospitalisations: falls, fractures (any and hip), pressure injury, urinary and faecal incontinence, myocardial infarction, heart failure, stroke, venous thromboembolism, pulmonary embolism, acute kidney injury, gastrointestinal bleeding, pneumonia, and sepsis. Fine-Gray subdistribution hazard models accounted for death as a competing risk and adjusted for socioeconomic covariates. FINDINGS: Over a maximum follow-up of 26 years, the median time to event was 1·2 years (IQR 0·2-3·3) in the delirium group and 1·3 years (0·3-3·6) in the control group. Delirium was associated with a higher risk of 12 of the 15 adverse clinical outcomes than no delirium, which were urinary incontinence (subdistribution hazard ratio 2·01 [95% CI 1·78-2·28]), falls (1·96 [1·78-2·17]), pressure injury (1·72 [1·53-1·93]), acute kidney injury (1·71 [1·57-1·86]), sepsis (1·67 [1·52-1·84]), hip fracture (1·66 [1·39-2·00]), stroke (1·62 [1·41-1·87]), overall fractures (1·56 [1·40-1·74]), pneumonia (1·53 [1·41-1·65]), faecal incontinence (1·53 [1·31-1·78]), heart failure (1·31 [1·18-1·45]), and gastrointestinal bleeding (1·23 [1·09-1·38]). Each additional episode was associated with a 6-17% higher risk. Findings were consistent across sensitivity analyses excluding individuals with short follow-up, those with prevalent dementia, and the least well-matched pairs. INTERPRETATION: In-hospital delirium was consistently and dose-responsively associated with a range of adverse outcomes, independent of frailty and pre-existing dementia, supporting its recognition as a sentinel event indicating longer-term vulnerability. FUNDING: Sigrid Jusélius Foundation, the Osk Huttunen Foundation, the Biomedicum Helsinki Foundation, and Finska Läkaresällskapet.
引用
- Haapanen MJ, Ward DD, Mudge AM, et al. Delirium and adverse clinical outcomes: a matched cohort study in the UK Biobank. Lancet Healthy Longev. 2026. PMID: 41679317. doi:10.1016/j.lanhl.2025.100816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。